| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1474-4422(10)70066-1 |
| P8608 | Fatcat ID | release_uec7fjdmq5dqzbyjzrwdy7zlxe |
| P698 | PubMed publication ID | 20227347 |
| P50 | author | Peter M. Rothwell | Q69146995 |
| P2093 | author name string | Eoin O'Brien | |
| Sally C Howard | |||
| Eamon Dolan | |||
| Neil R Poulter | |||
| Peter S Sever | |||
| Bjorn Dahlöf | |||
| Joanna E Dobson | |||
| ASCOT-BPLA and MRC Trial Investigators | |||
| P2860 | cites work | Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate | Q84399115 |
| Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 | ||
| MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party | Q24541570 | ||
| Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies | Q24658205 | ||
| Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies | Q28036762 | ||
| Regression dilution of systolic and diastolic blood pressure in patients with established cerebrovascular disease | Q28166076 | ||
| Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias | Q29616292 | ||
| Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A | Q33989952 | ||
| Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra | Q34189543 | ||
| Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study | Q34494252 | ||
| Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol | Q34522261 | ||
| Global burden of blood-pressure-related disease, 2001. | Q34775810 | ||
| Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials | Q34778622 | ||
| Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies | Q36561528 | ||
| Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group | Q36599327 | ||
| European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring | Q37214481 | ||
| Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis | Q37708610 | ||
| Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension | Q37708614 | ||
| Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial). | Q43275235 | ||
| Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats. | Q43696196 | ||
| Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke. | Q45921336 | ||
| Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy. | Q45974090 | ||
| Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients | Q46217490 | ||
| Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). | Q46695758 | ||
| Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. | Q51806116 | ||
| 2007 Guidelines for the Management of Arterial Hypertension | Q56970780 | ||
| Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention | Q57085525 | ||
| Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement | Q57085541 | ||
| Ambulatory blood pressure monitoring and 24-h blood pressure control as predictors of outcome in treated hypertensive patients | Q57281953 | ||
| Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party | Q67588661 | ||
| Medium-term variability of blood pressure and potential underdiagnosis of hypertension in patients with previous transient ischemic attack or minor stroke | Q79157081 | ||
| Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension | Q83185409 | ||
| Blood pressure reduction is not the only determinant of outcome | Q83978176 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 469-480 | |
| P577 | publication date | 2010-03-11 | |
| P1433 | published in | Lancet Neurology | Q15755067 |
| P1476 | title | Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke | |
| P478 | volume | 9 |
| Q56970511 | 2013 ESH/ESC Guidelines for the management of arterial hypertension |
| Q42722985 | A new dimension in hypertension management with the amlodipine/perindopril combination |
| Q44584567 | Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats |
| Q34546081 | Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study |
| Q36439201 | Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes. |
| Q35016314 | Adult hypertension is associated with blood pressure variability in childhood in blacks and whites: the bogalusa heart study |
| Q37828331 | Advances in Emerging Therapies 2010 |
| Q53795955 | Ambulatory 24-hour cardiac oxygen consumption and blood pressure-heart rate variability: effects of nebivolol and valsartan alone and in combination |
| Q57182255 | Ambulatory Blood Pressure Monitoring-Derived Short-Term Blood Pressure Variability in Primary Aldosteronism |
| Q26999957 | Ambulatory blood pressure monitoring in the diagnosis and management of hypertension |
| Q43830099 | Ambulatory blood pressure variability is associated with restenosis after percutaneous coronary intervention in normotensive patients |
| Q54567159 | Amlodipine reduces blood pressure during dynamic resistance exercise in hypertensive patients. |
| Q84468500 | Angiotensin receptor blockers following acute stroke |
| Q57486689 | Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension |
| Q48616324 | Artificial Cold Wave-Induced Cerebral Infarction in Rats with Carotid Atherosclerosis |
| Q38071134 | Assessing Blood Pressure Responses to Noncardiovascular Drugs: The Beneficial Role of Ambulatory Blood Pressure Monitoring |
| Q38102061 | Assessment and interpretation of blood pressure variability in a clinical setting |
| Q38080706 | Assessment and management of blood-pressure variability |
| Q40263598 | Assessment of Short-term Blood Pressure Variability in Patients With Ascending Aortic Dilatation. |
| Q38794924 | Association Between Long-Term Blood Pressure Variability and 10-Year Progression in Arterial Stiffness: The Multiethnic Study of Atherosclerosis. |
| Q34323765 | Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative |
| Q37696806 | Association between beat-to-beat blood pressure variability and vascular elasticity in normal young adults during the cold pressor test |
| Q40272737 | Association between mortality and blood pressure variability in hypertensive and normotensive elders: A cohort study. |
| Q36810511 | Association of BP Variability with Mortality among African Americans with CKD |
| Q44837340 | Association of Heart Rate With Blood Pressure Variability: Implications for Blood Pressure Measurement |
| Q33773182 | Association of blood pressure variability with orthostatic intolerance symptoms. |
| Q42977173 | Atenolol in uncomplicated hypertension: time for changes |
| Q89031828 | Baroreflex failure and beat-to-beat blood pressure variation |
| Q33607655 | Beneficial effect of calcium channel blockers on home blood pressure variability in the morning in patients with type 2 diabetes |
| Q35660819 | Benefits of once-daily therapies in the treatment of hypertension |
| Q26825409 | Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease |
| Q50578868 | Blood Pressure Lowering Medication, Visit-to-Visit Blood Pressure Variability, and Cognitive Function in Old Age. |
| Q90322709 | Blood Pressure Variability and Therapeutic Implications in Hypertension and Cardiovascular Diseases |
| Q38111902 | Blood Pressure Variability in Chronic Kidney Disease Patients |
| Q57780929 | Blood Pressure Variability in Elderly Persons With White-Coat and Masked Hypertension Compared to Those With Normotension and Sustained Hypertension |
| Q38101722 | Blood Pressure Variability: A Novel and Important Risk Factor |
| Q58995427 | Blood Pressure Variability: Prognostic Value and Therapeutic Implications |
| Q26996563 | Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses |
| Q46084842 | Blood pressure measurements, blood pressure variability and endothelial function in renal transplant recipients |
| Q42389945 | Blood pressure variability and dialysis: variability may not always be the spice of life. |
| Q57156061 | Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial |
| Q84955085 | Blood pressure variability and outcomes in chronic kidney disease |
| Q38189603 | Blood pressure variability assessed by home measurements: a systematic review |
| Q38097879 | Blood pressure variability in risk stratification: What does it add? |
| Q38168671 | Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination |
| Q38384167 | Blood pressure variability: assessment, predictive value, and potential as a therapeutic target |
| Q44404206 | Blood pressure variability: cardiovascular risk integrator or independent risk factor? |
| Q90591446 | Blood pressure variability: its relevance for cardiovascular homeostasis and cardiovascular diseases |
| Q36924802 | Can Ambulatory Blood Pressure Variability Contribute to Individual Cardiovascular Risk Stratification? |
| Q98613687 | Cardiovascular Risk Factors: It's Time to Focus on Variability! |
| Q38237353 | Cardiovascular risk stratification and blood pressure variability on ambulatory and home blood pressure measurement |
| Q26770734 | Central blood pressure and chronic kidney disease |
| Q95583761 | Change in Blood Pressure Variability Among Treated Elderly Hypertensive Patients and Its Association With Mortality |
| Q38379497 | China Stroke Primary Prevention Trial: Visit-to-Visit Systolic Blood Pressure Variability Is an Independent Predictor of Primary Stroke in Hypertensive Patients |
| Q91826478 | Clinical implication of visit-to-visit blood pressure variability |
| Q33804805 | Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring |
| Q38153194 | Clinical relevance of visit-to-visit blood pressure variability: impact on renal outcomes. |
| Q26995943 | Cognitive impairment and risk of future stroke: a systematic review and meta-analysis |
| Q48622723 | Comparing volume-clamp method and intra-arterial blood pressure measurements in patients with atrial fibrillation admitted to the intensive or medium care unit |
| Q49957629 | Comparison between L-type and N/L-type calcium channel blockers in the regulation of home blood-pressure variability in elderly hypertensive patients |
| Q90680465 | Depiction of Physiological Homeostasis by Self-Coupled System and Its Significance |
| Q41678564 | Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke |
| Q85307741 | Differences in mean and variability of heart rate and ambulatory rate-pressure product when valsartan or carvedilol is added to lisinopril |
| Q41585268 | Differing Effects of Aliskiren/Amlodipine Combination and High-Dose Amlodipine Monotherapy on Ambulatory Blood Pressure and Target Organ Protection |
| Q49108355 | Do level and variability of systolic blood pressure predict arterial properties or vice versa? |
| Q37090828 | Does Antihypertensive Drug Class Affect Day-to-Day Variability of Self-Measured Home Blood Pressure? The HOMED-BP Study |
| Q38260595 | Does blood pressure variability contribute to risk stratification? Methodological issues and a review of outcome studies based on home blood pressure |
| Q37861584 | Does blood pressure variability modulate cardiovascular risk? |
| Q38114646 | Drug treatments in the secondary prevention of ischaemic stroke |
| Q61798786 | Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke |
| Q35885368 | Effect of One-Week Salt Restriction on Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes |
| Q42697711 | Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment |
| Q34078174 | Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial |
| Q39481514 | Effect of inter-individual blood pressure variability on the progression of atherosclerosis in carotid and coronary arteries: a post hoc analysis of the NORMALISE and PREVENT studies |
| Q84080376 | Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats |
| Q37005906 | Effect of salt intake on beat-to-beat blood pressure nonlinear dynamics and entropy in salt-sensitive versus salt-protected rats |
| Q51019364 | Effect of single-pill irbesartan/amlodipine combination-based therapy on clinic and home blood pressure profiles in hypertension with chronic kidney diseases. |
| Q38971605 | Effects of Antihypertensive Therapy on Blood Pressure Variability |
| Q46721149 | Effects of Intensive Antihypertensive Treatment on Chinese Hypertensive Patients Older Than 70 Years |
| Q35949717 | Effects of Renal Sympathetic Denervation on 24-hour Blood Pressure Variability |
| Q37708610 | Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis |
| Q36453062 | Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial |
| Q53561370 | Effects of lercanidipine hydrochloride versus felodipine sustained-release on day-to-day home blood pressure variability |
| Q51371652 | Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study. |
| Q41187803 | Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease. |
| Q90426909 | Effects of vasodilating medications on cerebral haemodynamics in health and disease: systematic review and meta-analysis |
| Q57489973 | Effects on 24-hour blood pressure variability of ace-inhibition and calcium channel blockade as monotherapy or in combination |
| Q42705972 | Efficacy and safety of 10-mg azilsartan compared with 8-mg candesartan cilexetil in Japanese patients with hypertension: a randomized crossover non-inferiority trial |
| Q82317578 | Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability |
| Q43907431 | Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats |
| Q36754659 | Eplerenone restores 24-h blood pressure circadian rhythm and reduces advanced glycation end-products in rhesus macaques with spontaneous hypertensive metabolic syndrome |
| Q37966998 | Evidence for improvement in survival with antihypertensive combination treatment |
| Q36875577 | Exploring haemodynamics of haemodialysis using extrema points analysis model. |
| Q30378205 | External Counterpulsation Reduces Beat-to-Beat Blood Pressure Variability When Augmenting Blood Pressure and Cerebral Blood Flow in Ischemic Stroke |
| Q92310459 | Factors Associated with Visit-to-Visit Variability of Blood Pressure Measured as Part of Routine Clinical Care among Patients Attending Cardiology Outpatient Department of a Tertiary Care Centre in Northern Sri Lanka |
| Q63352847 | Factors associated with intra-individual visit-to-visit variability of blood pressure in four countries: the INTERMAP study. |
| Q34677369 | Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension |
| Q42563121 | Finding a Signal in the Noise |
| Q37681867 | Fluctuation in systolic blood pressure is a major systemic risk factor for development of primary open-angle glaucoma |
| Q33572879 | From Clinical Considerations to Theory - Blood Pressure Variability Profiles and Patterns |
| Q38113155 | Gender Differences in Hypertension: Myths and Reality |
| Q37359289 | Genetic and environmental influences on blood pressure variability: a study in twins. |
| Q30410548 | Genome-wide analysis of blood pressure variability and ischemic stroke |
| Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
| Q53506107 | Healthy Lifestyle and Blood Pressure Variability in Young Adults |
| Q47991464 | Hemodynamic Determinants of the Short-Term Blood Pressure Variability: Differential Roles of Arterial Stiffness and Wave Reflection |
| Q28088545 | Heterogeneity of prognostic studies of 24-hour blood pressure variability: systematic review and meta-analysis |
| Q36991761 | High Short-Term Blood Pressure Variability Predicts Long-Term Cardiovascular Mortality in Untreated Hypertensives But Not in Normotensives |
| Q37382589 | High Systolic and Diastolic Blood Pressure Variability Is Correlated with the Occurrence of Peripheral Arterial Disease in the First Decade following a Diagnosis of Type 2 Diabetes Mellitus: A New Biomarker from Old Measurement |
| Q38922597 | High blood pressure variability predicts 30-day mortality but not 1-year mortality in hospitalized elderly patients |
| Q36713754 | Home blood pressure variability as cardiovascular risk factor in the population of Ohasama |
| Q86841776 | Home blood pressure variability: a new target to monitor in chronic kidney disease patients with low eGFR? |
| Q84865106 | Home monitoring is the optimal method for assessing blood pressure variability |
| Q55889453 | Hypertension |
| Q86815438 | Hypertension - a clinical update for physicians |
| Q38544562 | Hypertension and Stroke: Epidemiological Aspects and Clinical Evaluation. |
| Q56343865 | Hypertension and intracerebral hemorrhage recurrence among white, black, and Hispanic individuals |
| Q53566357 | Hypertension control and cardiovascular disease. |
| Q34194758 | Hypertension management 2011: optimal combination therapy |
| Q38784663 | Hypertension, Blood Pressure Variability, and Target Organ Lesion. |
| Q35194130 | Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study |
| Q90397420 | Impact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohort |
| Q42723610 | Importance of blood pressure variability in the assessment of cardiovascular risk and benefits of antihypertensive therapy |
| Q48355197 | Increase Trend in Home Blood Pressure on a Single Occasion Is Associated With B-Type Natriuretic Peptide and the Estimated Glomerular Filtration Rate |
| Q37448532 | Increased Blood Pressure Variability Is Associated with Worse Neurologic Outcome in Acute Anterior Circulation Ischemic Stroke. |
| Q85023975 | Increased Intervisit Blood Pressure Variability and β-Blockade: Measurement Imprecision Related to Bradycardia? |
| Q56374096 | Increasing SBP variability is associated with an increased risk of developing incident diabetic foot ulcers |
| Q35886033 | Incremental Blood Pressure-Lowering Effect of Titrating Amlodipine for the Treatment of Hypertension in Patients Including Those Aged ≥55 Years |
| Q58363032 | Influence of Renin Angiotensin System Gene Polymorphisms on Visit-to-Visit Blood Pressure Variability in Hypertensive Patients |
| Q38615351 | Influence of beat-to-beat blood pressure variability on vascular elasticity in hypertensive population |
| Q57816063 | Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial) |
| Q37486932 | Investigation on cardiovascular risk prediction using physiological parameters |
| Q38583208 | Is It Daily, Monthly, or Yearly Blood Pressure Variability that Enhances Cardiovascular Risk? |
| Q83810771 | Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment? |
| Q43908383 | Labile Hypertension: Characteristics of a Referred Cohort |
| Q38586842 | Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies |
| Q52689065 | Lercanidipine in the Management of Hypertension: An Update. |
| Q84358080 | Letter by Lagro et al Regarding Article, “Average Daily Blood Pressure, Not Office Blood Pressure, Is Associated With Progression of Cerebrovascular Disease and Cognitive Decline in Older People” |
| Q93576600 | Letters to the editor |
| Q37708614 | Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension |
| Q51017958 | Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-Analysis |
| Q91207877 | Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial |
| Q38903836 | Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study. |
| Q44096808 | Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease |
| Q36008200 | Magnetic Resonance Imaging Measurement of Transmission of Arterial Pulsation to the Brain on Propranolol Versus Amlodipine |
| Q26864615 | Management of hypertension in children with cardiovascular disease and heart failure |
| Q37875489 | Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke |
| Q30666766 | Medication class effects on visit-to-visit variability of blood pressure measurements: analysis of electronic health record data in the "real world". |
| Q89304769 | Metoprolol has a similar therapeutic effect as amlodipine on BP lowering in hypertensive patients with obstructive sleep apnea |
| Q38193200 | Models for evaluating the pharmacokinetics and pharmacodynamics for β-blockers |
| Q28085132 | Molecular mechanism of aggravation of hypertensive organ damages by short-term blood pressure variability |
| Q38120337 | Most Important Outcomes Research Papers on Hypertension |
| Q90950057 | Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension |
| Q35085669 | Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies. |
| Q35106572 | Optimal combination secondary prevention drug treatment and stroke outcomes |
| Q64119821 | Patient Judgments About Hypertension Control: The Role of Variability, Trends, and Outliers in Visualized Blood Pressure Data |
| Q45940243 | Patterns of blood pressure response during intensive BP lowering and clinical events: results from the secondary prevention of small subcortical strokes trial. |
| Q57171539 | Peak lung function during young adulthood and future long-term blood pressure variability: The Coronary Artery Risk Development in Young Adults (CARDIA) study |
| Q37877722 | Perindopril for the treatment of hypertension. |
| Q47626124 | Physical activity phenotyping with activity bigrams, and their association with BMI. |
| Q40050019 | Postoperative blood pressure variability exerts an influence on clinical outcome after coil embolization of ruptured intracranial aneurysms |
| Q36061968 | Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis. |
| Q90081064 | Preoperative outpatient blood pressure variability predicts postoperative mortality, readmission and morbidity after surgery |
| Q36255961 | Prognostic Impact of Blood Pressure Variability on Aortic Dissection Patients After Endovascular Therapy |
| Q49266455 | Prognostic Significance of Blood Pressure Variability on Beat-to-Beat Monitoring After Transient Ischemic Attack and Stroke |
| Q58127014 | Prognostic Significance of Pulse Pressure Variability During Mechanical Thrombectomy in Acute Ischemic Stroke Patients |
| Q26799050 | Prognostic Significance of Short-Term Blood Pressure Variability in Acute Stroke: Systematic Review |
| Q83185409 | Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension |
| Q37577166 | Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes |
| Q40272769 | Prognostic value of long-term blood pressure changes in patients with chronic heart failure |
| Q48343829 | Proposal of RAS-diuretic vs. RAS-calcium antagonist strategies in high-risk hypertension: insight from the 24-hour ambulatory blood pressure profile and central pressure |
| Q48170240 | Quantifying the speed of fluctuations in systolic blood pressure |
| Q64236240 | Randomised controlled trial of a Calcium Channel or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Regime to Reduce Blood Pressure Variability following Ischaemic Stroke (CAARBS): a protocol for a feasibility study |
| Q28654977 | Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the Systolic Hypertension in Europe trial |
| Q33754223 | Redefined blood pressure variability measure and its association with mortality in elderly primary care patients |
| Q41481415 | Reduced blood pressure variability in ASCOT-BPLA trial favours use of amlodipine/perindopril combination to reduce stroke risk. |
| Q83185914 | Reducing blood pressure variability to prevent stroke? |
| Q90653818 | Relationship between Within-Visit Blood Pressure Variability and Skeletal Muscle Mass |
| Q64903076 | Relationship of Inter-Individual Blood Pressure Variability and the Risk for Recurrent Stroke. |
| Q33736858 | Response of day-to-day home blood pressure variability by antihypertensive drug class after transient ischemic attack or nondisabling stroke |
| Q33565681 | Role of vascular KATP channels in blood pressure variability after sinoaortic denervation in rats |
| Q88671092 | Seasonal blood pressure variation: implications for cardiovascular risk stratification |
| Q30313535 | Short-term blood pressure variability - variation between arm side, body position and successive measurements: a population-based cohort study |
| Q84903891 | Should β blockers no longer be considered first-line therapy for the treatment of essential hypertension without comorbidities? |
| Q37672178 | Significance of Cardiac Rehabilitation on Visit-to-Visit Variability of Blood Pressure in Patients With Cardiovascular Disease in a 12-Month Follow-Up |
| Q46113773 | Slowing chronic kidney disease progression: should we be looking beyond mean blood pressure? |
| Q83185372 | Stroke and blood-pressure variation: new permutations on an old theme |
| Q36822707 | Systolic Blood Pressure Variability is a Novel Risk Factor for Rebleeding in Acute Subarachnoid Hemorrhage: A Case-Control Study |
| Q39065150 | Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: a retrospective cohort study |
| Q30277672 | Systolic blood pressure variability and lower extremity amputation in a non-elderly population with diabetes |
| Q28487721 | The Effects of Calcium Channel Blockers in the Prevention of Stroke in Adults with Hypertension: A Meta-Analysis of Data from 273,543 Participants in 31 Randomized Controlled Trials |
| Q92377672 | The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
| Q45861292 | The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial |
| Q33623767 | The association between within-visit blood pressure variability and carotid artery atherosclerosis in general population |
| Q35183592 | The current status of beta blockers' use in the management of hypertension |
| Q37987036 | The effect of antihypertensive treatment on headache and blood pressure variability in randomized controlled trials: a systematic review |
| Q33624507 | The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: results from a multicenter randomized controlled trial |
| Q44915857 | The impact of aerobic exercise on blood pressure variability |
| Q37397083 | The impact of blood pressure variability on subclinical ventricular, renal and vascular dysfunction, in patients with hypertension and diabetes |
| Q58363158 | The impact of visit-to-visit variability in blood pressure on renal function |
| Q39852297 | The importance of instability and visit-to-visit variability of blood pressure |
| Q45105236 | The predictive ability of blood pressure in elderly trial patients |
| Q64054401 | The relationship between visit-to-visit variability in blood pressure and incidence of metabolic syndrome: a general population-based cohort study in Korea |
| Q39084522 | The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease |
| Q36318830 | The risk of diabetic renal function impairment in the first decade after diagnosed of diabetes mellitus is correlated with high variability of visit-to-visit systolic and diastolic blood pressure: a case control study |
| Q34237456 | The role of blood pressure variability in the development of nephropathy in type 1 diabetes |
| Q38243976 | Thiazide-like/calcium channel blocker agents: a major combination for hypertension management |
| Q52371823 | Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication. |
| Q35648075 | Treatment of Risk Factors to Prevent Stroke |
| Q35737326 | Trends in Prevalence, Awareness, Treatment and Control of Hypertension during 2001-2010 in an Urban Elderly Population of China |
| Q36028685 | Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991–2009 |
| Q37833661 | Twenty-four-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation |
| Q38373048 | Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial). |
| Q38371166 | Visit-to-Visit Variability of Systolic Blood Pressure and Cardiovascular Disease. |
| Q37100807 | Visit-to-visit and 24-h blood pressure variability: association with endothelial and smooth muscle function in African Americans. |
| Q38060964 | Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases |
| Q87110174 | Visit-to-visit blood pressure variability is related to albuminuria variability and progression in patients with type 2 diabetes |
| Q30275840 | Visit-to-visit systolic blood pressure variability and microvascular complications among patients with diabetes |
| Q34441259 | Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. |
| Q37966995 | Which patients benefit the most from the perindopril/amlodipine combination |
| Q55018560 | Will the recent hypertension trials change the guidelines? |
| Q26738841 | Within-Home Blood Pressure Variability on a Single Occasion Has Clinical Significance |
| Q36713377 | Within-subject blood pressure level--not variability--predicts fatal and nonfatal outcomes in a general population |
| Q48246287 | Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease. |
| Q34965730 | Within-visit blood pressure variability is associated with prediabetes and diabetes |
| Q44018927 | Within-visit blood pressure variability: relevant factors in the general population. |
| Q84041146 | [Update Stroke Conference 2011: International Stroke Conference 2011, Los Angeles, USA] |
Search more.